Medicine

Case Solution for Yunnan Baiyao: Traditional Medicine Meets Product/Market Diversification
Complete Case details are given below :
Case Name :      Yunnan Baiyao: Traditional Medicine Meets Product/Market Diversification
Authors :           Paul W. Beamish, George Peng
Source :             Ivey Publishing
Case ID :            906M88
Discipline :        Strategy
Case Length :    17 pages
Solution Sample availability : YES
Plagiarism : NO (100% Original work)
Description for case is given below :
In 2003, 3M initiated contact with Yunnan Baiyao Group Co., Ltd. to discuss potential cooperation opportunities in the area of transdermal pharmaceutical products. Yunnan Baiyao (YB), was a household brand in China for its unique traditional herbal medicines. In recent years, the company had been engaged in a series of corporate reforms and product/market diversification strategies to respond to the change in the Chinese pharmaceutical industry and competition at a global level. By 2003, YB was already a vertically integrated, product-diversified group company with an ambition to become an international player. The proposed cooperation with 3M was attractive to YB, not only as an opportunity for domestic product diversification, but also for international diversification. YB had been attempting to internationalize its products and an overseas department had been established in 2002 specifically for this purpose. On the other hand, YB had also been considering another option, namely, whether to extend its brand to toothpaste and other healthcare products. YB had to make decisions about which of the two options to pursue and whether it was feasible to pursue both.
 
Click Here to place your order
 
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
 
Cordially,
Case Solutions Hub

Case Solution for Schulich School of Medicine: Enhancing and Developing a High-Performance Culture
Complete Case details are given below :
Case Name :      Schulich School of Medicine: Enhancing and Developing a High-Performance Culture
Authors :           Murray J. Bryant, Ken Mark
Source :             Ivey Publishing
Case ID :            909M14
Discipline :        General Management
Case Length :    03 pages
Solution Sample availability : YES
Plagiarism : NO (100% Original work)
Description for case is given below :
The newly appointed chair of the Department of Physiology and Pharmacology (department) at the Schulich School of Medicine & Dentistry was thinking about how she would approach the next five year in her new role. The chair thought about two of the important issues she would face: building a cohesive department and nurturing a high performance culture. She became chair at a time when direction was needed. The department had formed in June 2002 as a result of the merger between the Department of Physiology and the small Department of Pharmacology & Toxicology. While the merger had gone well, the chair still sensed that some faculty members in Pharmacology felt as if their department had been taker over by Physiology. At present, it was sometimes difficult to assess performance between faculty members due to differences in workload composition and a lack of documentation. The current thinking was that the department had to move towards adopting best practices in their processes. The chair wanted to look at the issue from a broader perspective. She wondered how the issue could be best framed and what a potential solution might look like.
 
Click Here to place your order
 
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
 
Cordially,
Case Solutions Hub

Case Solution for Intelligent Medicine: The Novartis-Proteus Alliance
Complete Case details are given below :
Case Name :      Intelligent Medicine: The Novartis-Proteus Alliance
Authors :           Anirudh Dhebar
Source:              Babson College
Case ID:             BAB696
Discipline :        Marketing
Case Length :    06 pages
Solution sample availability : YES
Plagiarism : NO (100% Original work)
Description for case is given below :
Novartis’s investment in the start-up Proteus Biomedical gave the pharmaceuticals giant access to a technology allowing for the implantation of ingestible sensors in medicinal pills and, with the help of the sensors, the collection and wireless transmission of drug-compliance data to healthcare providers for the review of pre-determined health vitals. One application of the technology was the improvement of drug compliance: if, for some reason, such “smart pills” were not taken as prescribed, patients could be reminded to comply with the recommended medication regime. The case, which is brief and based on public information, summarizes the nature and magnitude of the drug noncompliance problem, describes some of the competing solutions to address the problem, outlines Proteus’s technology in this context, profiles the Proteus and Novartis enterprises, and concludes by characterizing the challenge in front of Novartis as it decides which pill(s) to make smart and how best to market the smart pill(s). The proposed thrust

Click Here to place your order
 
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
 
Cordially,
Case Solutions Hub